Institutional investors purchased a net $3.7 million shares of ONTY during the quarter ended March 2015 and now own 58.73% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN ADVISERS, INC. Bought 3.5 Million shares of Oncothyreon Inc
BROADFIN CAPITAL LLC Bought 1.5 Million shares of Oncothyreon Inc
VENBIO SELECT ADVISOR LLC Bought 1.5 Million shares of Oncothyreon Inc